The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population
- 1 May 2006
- journal article
- clinical trial
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 16 (3) , 1007-1013
- https://doi.org/10.1111/j.1525-1438.2006.00460.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A Large Case‐Control Study of Cervical Cancer Risk Associated with Human Papillomavirus Infection in Japan, by Nucleotide Sequencing–Based GenotypingThe Journal of Infectious Diseases, 2004
- Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for ScreeningObstetrics & Gynecology, 2004
- Management of women who test positive for high-risk types of human papillomavirus: the HART studyThe Lancet, 2003
- Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patientsBritish Journal of Cancer, 2003
- Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray methodCancer, 2003
- Baseline Cytology, Human Papillomavirus Testing, and Risk for Cervical Neoplasia: A 10-Year Cohort AnalysisJNCI Journal of the National Cancer Institute, 2003
- Papillomaviruses and cancer: from basic studies to clinical applicationNature Reviews Cancer, 2002
- The causal relation between human papillomavirus and cervical cancerJournal of Clinical Pathology, 2002
- Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 womenBritish Journal of Cancer, 2001
- Relationship Between Serum Carotenoid Levels and Cancer Death Rates in the Residents, Living in a Rural Area of Hokkaido, JapanJournal of Epidemiology, 1997